直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Drafting Effective Pharmaceutical Claims with an Eye Towards the USFDA Orange Book

March 23, 2010

London, United Kingdom

Management Forum

Finnegan attorneys Anthony Tridico and Elizabeth Doherty will present at the Management Forum seminar on "Effective Pharmaceutical Claims with an Eye Towards the USFDA." The seminar will discuss claim drafting strategies for U.S. pharmaceutical patents, U.S. patents with an eye towards the Orange Book, patent term extensions, ANDA litigation in the U.S., and legislative proposals concerning biologic drugs and follow-on biologics. For more information about the program, please visit the Management Forum's website.

Related Practices

Global IP Enforcement, Litigation, and Trials

Prosecution and Portfolio Management

Related Industries

Life Sciences

Pharmaceutical

Biologics

Related Professionals

Anthony C. Tridico, Ph.D.
Partner
Washington, DC
+1 202 408 4173
Email

Related Insights

Conference

Life Sciences Patent Network North America Fall 2026

November 2-3, 2026

San Francisco

Conference

LES 2026 Annual Meeting

October 18-21, 2026

San Diego

Conference

Georgia Life Sciences Summit 2026

August 25-26, 2026

Sandy Springs

At the PTAB Blog

Squires Issues Precedential Decision Clarifying Obviousness-Type Double Patenting Rejections

August 17, 2026

Conference

13th Annual Summit for Women Leaders in Life Sciences Law

July 29-30, 2026

Boston

Conference

2026 China Pharmaceutical Innovation Conference

July 22-24, 2026

Shanghai

Federal Circuit IP Blog

“2” Does Not Provide Written Description Support for “1”: Federal Circuit Affirms District Court’s Invalidation of Patent

July 8, 2026

Articles

Genus Claiming (Including Means Plus Function “MPF” Claiming) in Biotech and Pharma: Doctrinal Trajectory and Drafting Strategies

June 2026

Federal Circuit IP Blog

Federal Circuit Affirms Noninfringement Ruling in Hatch-Waxman Litigation Based on Claim Construction, Prosecution History Estoppel, and the Disclosure-Dedication Rule

June 26, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP